End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.26 CNY | +2.94% | -7.21% | -39.04% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 14.13 for the current year.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-39.04% | 363M | - | ||
-8.74% | 60.39B | A- | ||
+65.24% | 45.4B | B | ||
+14.54% | 38.12B | B | ||
+0.50% | 31.28B | A- | ||
+7.38% | 19.67B | B- | ||
+10.83% | 16.52B | C+ | ||
+7.90% | 13.8B | B- | ||
-5.22% | 12.96B | B | ||
-23.61% | 12.42B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 688357 Stock
- Ratings Luoyang Jianlong Micro-nano New Material Co., Ltd